Bemarituzumab [1952272-74-0]
M21498
Product group Antibodies
Overview
- SupplierAbMole BioScience
- Product NameBemarituzumab [1952272-74-0]
- Delivery Days Customer7
- CAS Number1952272-74-0
- CertificationResearch Use Only
- Estimated Purity＞99%
- Scientific DescriptionBemarituzumab (FPA144) is a first-in-class, humanized, afucosylated immunoglobulin G1 monoclonal antibody (mAb) directed against fibroblast growth factor receptor 2b (FGFR2b) with two mechanisms of action against FGFR2b-overexpressing tumors: inhibition of FGFR2b signaling and enhanced antibody-dependent cell-mediated cytotoxicity (ADCC).
- Storage Instruction-20°C
- UNSPSC41116161